General information about company

Scrip code524572
NSE Symbol
MSEI Symbol
ISININE117D01018
Name of the entityPharmaids Pharmaceuticals Limited
Date of start of financial year01-04-2025
Date of end of financial year31-03-2026
Reporting Quarter TypeQuarterly
Date of Quarter Ending30-06-2025
Type of companyEquity
Whether Annexure I (Part A) of the SEBI Circular dated December 31, 2024 related to Compliance Report on Corporate Governance is applicable to the entity?Yes
Whether Annexure I (Part B) of the SEBI Circular dated December 31, 2024 related to Investor Grievance Redressal Report is Applicable to the entity?Yes
Whether Annexure I (Part C) of the SEBI Circular dated December 31, 2024 related to Disclosure of Acquisition of Shares or Voting Rights in Unlisted Companies is Applicable to the entity?NoThere are no acquisitions of shares or voting rights in unlisted Companies during the Quarter ended June 30, 2025.
Whether Annexure I (Part D) of the SEBI Circular dated December 31, 2024 related to Disclosure of Imposition of Fine or Penalty is Applicable to the entity?NoThere are no penlaty or fines imposed during the quarter ended June 30, 2025 in terms of sub-para 20 of para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclousre Requirements) Regulations, 2015.
Whether Annexure I (Part E) of the SEBI Circular dated December 31, 2024 related to Disclosure of Updates to Ongoing Tax Litigations or Disputes is Applicable to the entity?NoThere are no tax litigations or disputes as on June 30, 2025, as per Annexure I (Part E) of the SEBI Circular dated December 31, 2024
Risk management committeeNot Applicable
Market Capitalisation as per immediate previous Financial YearAny other
Is SCORE ID Available ?Yes
SCORE Registration IDP00115
Reason For No SCORE ID
Type of SubmissionOriginal
Remarks (website dissemination)
Remarks for Exchange (not for Website Dissemination)



Annexure I

Annexure I to be submitted by listed entity on quarterly basis

I. Composition of Board of Directors

Disclosure of notes on composition of board of directors explanatory
Whether the listed entity has a Regular ChairpersonYes
Whether Chairperson is related to MD or CEONo
SrTitle (Mr / Ms)Name of the DirectorPANDINCategory 1 of directorsCategory 2 of directorsCategory 3 of directors Date of Birth
1MrVENU MADHAVA KAPARTHY AAWPM7874Q00021699Executive DirectorNot Applicable11-07-1969
2MsMINI MANIKANTANAPYPM4112Q09663184Executive DirectorNot Applicable22-11-1984
3MrSHANKARAPPA NAGARAJA VINAYA BABUAEJPV9478A01373832Non-Executive - Non Independent DirectorChairperson14-10-1975
4MrSHREEDHARA SHETTYABIPS7646D02776638Non-Executive - Non Independent DirectorNot Applicable05-03-1959
5MrPATTAMADAI NATARAJASARMA VIJAYAABPV0419M00049992Non-Executive - Independent DirectorNot Applicable10-07-1951
6MrMETHUKU NAGESHABKPN5316R01634324Non-Executive - Independent DirectorNot Applicable16-06-1967
7MrMOPPERTHY SUDHEERATWPS0062R00404917Non-Executive - Independent DirectorNot Applicable01-01-1974

I. Composition of Board of Directors

Disqualification of Directors under section 164 of the Companies Act, 2013

SrWhether the director is disqualified?Start Date of disqualificationEnd Date of disqualificationDetails of disqualificationCurrent status
1NoActive
2NoActive
3NoActive
4NoActive
5NoActive
6NoActive
7NoActive

I. Composition of Board of Directors

SrWhether special resolution passed? [Refer Reg. 17(1A) of Listing Regulations]Date of passing special resolutionInitial Date of appointmentDate of Re-appointmentDate of cessationTenure of director (in months)No of Directorship in listed entities including this listed entity (Refer Regulation 17A of Listing Regulations)No of Independent Directorship in listed entities including this listed entity [with reference to proviso to regulation 17A(1) & reg. 17A(2)]Number of memberships in Audit/ Stakeholder Committee(s) including this listed entity (Refer Regulation 26(1) of Listing Regulations)No of post of Chairperson in Audit/ Stakeholder Committee held in listed entities including this listed entity (Refer Regulation 26(1) of Listing Regulations)Reason for CessationNotes for not providing PANNotes for not providing DIN
1NA21-05-202221-05-20251020
2NA09-07-20221010
3NA31-01-20241000
4NA29-08-20231000
5NA31-10-202231-10-202232.012232
6NA29-11-202229-11-202231.021121
7NA29-09-201506-01-2021117.021110



Audit Committee Details

Whether the Audit Committee has a Regular ChairpersonYes
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks
100021699VENU MADHAVA KAPARTHY Executive DirectorMember21-05-2022
201634324METHUKU NAGESHNon-Executive - Independent DirectorMember29-11-2022
300049992PATTAMADAI NATARAJASARMA VIJAYNon-Executive - Independent DirectorChairperson29-11-2022
400404917MOPPERTHY SUDHEERNon-Executive - Independent DirectorMember04-08-2023


Nomination and remuneration committee

Whether the Nomination and remuneration committee has a Regular ChairpersonYes
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks
101634324METHUKU NAGESHNon-Executive - Independent DirectorMember29-11-2022
200049992PATTAMADAI NATARAJASARMA VIJAYNon-Executive - Independent DirectorChairperson29-11-2022
300404917MOPPERTHY SUDHEERNon-Executive - Independent DirectorMember29-08-2023
401373832SHANKARAPPA NAGARAJA VINAYA BABUNon-Executive - Non Independent DirectorMember28-05-2024


Stakeholders Relationship Committee

Whether the Stakeholders Relationship Committee has a Regular ChairpersonYes
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks
100021699VENU MADHAVA KAPARTHY Executive DirectorMember21-05-2022
209663184MINI MANIKANTANExecutive DirectorMember09-07-2022
301634324METHUKU NAGESHNon-Executive - Independent DirectorChairperson29-11-2022


Risk Management Committee

Whether the Risk Management Committee has a Regular Chairperson
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks


Corporate Social Responsibility Committee

Whether the Corporate Social Responsibility Committee has a Regular Chairperson
SrDIN NumberName of Committee membersCategory 1 of directorsCategory 2 of directorsDate of Appointment Date of CessationRemarks


Other Committee

SrDIN NumberName of Committee membersName of other committeeCategory 1 of directorsCategory 2 of directorsRemarks

Annexure 1

Annexure 1

III. Meeting of Board of Directors

Disclosure of notes on meeting of board of directors explanatory
Sr. No.Date(s) of meeting (if any) in the previous quarterDate(s) of meeting (if any) in the current quarterMaximum gap between any two consecutive (in number of days)Notes for not providing DateWhether requirement of Quorum met (Yes/No)Total Number of Directors as on date of the meetingNumber of Directors present* (All directors including Independent Director)No. of Independent Directors attending the meeting*
112-02-2025Yes773
223-05-202599Yes762



Annexure 1

IV. Meeting of Committees

Disclosure of notes on meeting of committees explanatory
SrName of CommitteeDate(s) of meeting (Enter dates of Previous quarter and Current quarter in chronological order)Maximum gap between any two consecutive (in number of days)Name of other committeeReason for not providing dateWhether requirement of Quorum met (Yes/No)Total Number of Directors in the Committee as on date of the meetingNumber of Directors Present (All Directors including Independent Director)No. of Independent Directors attending the meeting* No. of members attending the meeting (other than Board of Directors)
1Audit Committee12-02-2025Yes4430
2Audit Committee23-05-202599Yes4320
3Stakeholders Relationship Committee18-03-2025Yes3310
4Nomination and remuneration committee12-02-2025Yes4430



Annexure 1

V. Affirmations

SrSubjectCompliance status (Yes/No)
1The composition of Board of Directors is in terms of SEBI (Listing obligations and disclosure requirements) Regulations, 2015Yes
2The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015 a. Audit CommitteeYes
3The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. b. Nomination & remuneration committeeYes
4The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. c. Stakeholders relationship committeeYes
5The composition of the following committees is in terms of SEBI(Listing obligations and disclosure requirements) Regulations, 2015. d. Risk management committee (applicable to the top 1000 listed entities)NA
6The committee members have been made aware of their powers, role and responsibilities as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015.Yes
7The meetings of the board of directors and the above committees have been conducted in the manner as specified in SEBI (Listing obligations and disclosure requirements) Regulations, 2015.Yes
8This report and/or the report submitted in the previous quarter has been placed before Board of Directors.Yes

Annexure 1

SrSubjectCompliance status
1Name of signatoryPrasanna Subramanya Bhat
2DesignationCompany Secretary and Compliance Officer



Details of Cyber security incidence

Whether as per Regulation 27(2)(ba) of SEBI (LODR) Regulations, 2015 there has been cyber security incidents or breaches or loss of data or documents during the quarterNo
Number of cyber security incidence or breaches or loss of data event occurred during the quarter
Sr.Date of the eventBrief details of the event



Signatory Details

Name of signatoryPrasanna Subramanya Bhat
Designation of personCompany Secretary and Compliance Officer
PlaceBengaluru
Date28-07-2025



Investor Grievance Details

No. of investor complaints pending at the beginning of Quarter0
No. of investor complaints received during the Quarter0
No. of investor complaints disposed off during the Quarter0
No. of investor complaints those remaining unresolved at the end of the Quarter0